Genérico Cyclophosphamide - Cytoxan

Cyclophosphamide drug makes the bone marrow more tumor-friendlyNews-Medical.

Family Practice News Digital NetworkDocs Need Primer on Long-Term Effects of ChemotherapyFamily Practice News Digital NetworkOnly 6% of primary care physicians were able to identify the main long-term effects (LEs) of doxorubicin (Adriamycin), paclitaxel (Taxol), oxaliplatin (Eloxatin), and cyclophosphamide (Cytoxan), compared with 65% of oncologists surveyed.

Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?Cancer NetworkIn their review article in this issue of ONCOLOGY, Nastoupil, Rose, and Flowers discuss the progress from the older chemotherapy regimen, CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), to immuno-chemotherapy.

OncLiveIs There a Best Adjuvant Chemotherapy Regimen for Breast Cancer?OncLiveCytotoxic therapy consisting of cyclophosphamide– methotrexate–5-fluorouracil (CMF)-based regimens showed a 24% reduction in breast cancer recurrence and 14% reduction in death, compared with placebo.

Clinical Oncology NewsFirst cycle G-CSF for high-risk chemotherapy: Of Course!Clinical Oncology NewsDawn Hershman, MD, of Columbia University in New York City, recently published an article in the Journal of Clinical Oncology noting the rapid uptake of dose-dense AC-Taxol (doxorubicin and cyclophosphamide followed by paclitaxel [ddAC-T]).